Matches in Nanopublications for { ?s ?p "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP574872.RAfjzEn6BLNva4amcjRYZu3ZygwrEGixsc0WdDqUu62Ic130_assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574872.RAfjzEn6BLNva4amcjRYZu3ZygwrEGixsc0WdDqUu62Ic130_provenance.
- NP574878.RAQoUF6oXrvoFbGRGTKvrvXl-VZOmM50HBFcEc6Vu1DBk130_assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574878.RAQoUF6oXrvoFbGRGTKvrvXl-VZOmM50HBFcEc6Vu1DBk130_provenance.
- assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP458972.RAci3Jhs-cbpLLClB-kQ4Qdu57OBOJe8wQkc7_e2NQ9j8130_assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458972.RAci3Jhs-cbpLLClB-kQ4Qdu57OBOJe8wQkc7_e2NQ9j8130_provenance.
- NP130878.RA5urTfbX6sFePjacNYVJtFkR9dCtf0e6v0HUQ-s4VVvo130_assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP130878.RA5urTfbX6sFePjacNYVJtFkR9dCtf0e6v0HUQ-s4VVvo130_provenance.
- NP458971.RA23STLQRYoI9E3taHPMZN15Gq_t20kdT1FQ0iVf8n0ao130_assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458971.RA23STLQRYoI9E3taHPMZN15Gq_t20kdT1FQ0iVf8n0ao130_provenance.
- NP87761.RA-PgdPztkGftZQ763yL0GJAIWOTFGrojv8Xop2GQkLHc130_assertion description "[Determination of MTHFR polymorphisms and CAG repeats enables screening for subjects with putative early HD onset in order to study neuroprotective compounds in their efficacy to delay HD symptoms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87761.RA-PgdPztkGftZQ763yL0GJAIWOTFGrojv8Xop2GQkLHc130_provenance.